Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Research

• Publication date

  2012-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-12-2271PMID 22850422PMCID PMC3652570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.

  2011cited by this paper
• Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

  2011cited by this paper
• Plasmacytoid dendritic cells and cancer

  2011cited by this paper
• The parallel lives of angiogenesis and immunosuppression: cancer and other tales

  2011cited by this paper
• Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.

  2011cited by this paper
• Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo.

  2011cited by this paper
• Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer.

  2010cited by this paper
• Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells.

  2010cited by this paper
• Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

  2009cited by this paper
• Impairment of Plasmacytoid Dendritic Cells for IFN Production by the Ligand for Immunoglobulin-Like Transcript 7 Expressed on Human Cancer Cells

  2009cited by this paper
• Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells

  2008cited by this paper
• Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.

  2008cited by this paper
• Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.

  2008cited by this paper
• Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma

  2008cited by this paper
• Plasmacytoid dendritic cells mediate oral tolerance.

  2008cited by this paper
• The impact of T‐cell immunity on ovarian cancer outcomes

  2008cited by this paper
• Plasmacytoid dendritic cells prime IL-10–producing T regulatory cells by inducible costimulator ligand

  2007cited by this paper
• Dendritic Cells Infiltrating Human Non-Small Cell Lung Cancer Are Blocked at Immature Stage1

  2007cited by this paper
• Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

  2007cited by this paper
• Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts

  2006cited by this paper
• The ICOS Molecule Plays a Crucial Role in the Development of Mucosal Tolerance1

  2005cited by this paper
• Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

  2005cited by this paper
• The Expression of the Regulatory T Cell–Specific Forkhead Box Transcription Factor FoxP3 Is Associated with Poor Prognosis in Ovarian Cancer

  2005cited by this paper
• Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.

  2005cited by this paper
• Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

  2005cited by this paper
• Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment

  2005cited by this paper
• Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• The Inducible CXCR3 Ligands Control Plasmacytoid Dendritic Cell Responsiveness to the Constitutive Chemokine Stromal Cell–derived Factor 1 (SDF-1)/CXCL12

  2003cited by this paper
• Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.

  2003cited by this paper
• Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas

  2003cited by this paper
• Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

  2003cited by this paper
• Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids

  2003cited by this paper
• Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity

  2002cited by this paper
• Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma

  2002cited by this paper
• Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

  2001cited by this paper
• Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

  2001cited by this paper
• Induction of Ovarian Tumor‐Specific CD8+ Cytotoxic T Lymphocytes by Acid‐Eluted Peptide‐Pulsed Autologous Dendritic Cells

  2000cited by this paper
• Topical imiquimod treatment of a cutaneous melanoma metastasis.

  2000cited by this paper
• Imiquimod applied topically: a novel immune response modifier and new class of drug.

  1999cited by this paper
• Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.

  1999cited by this paper
• Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

  1995cited by this paper

• Integrative analysis of bulk and single-cell transcriptomics identifies factors related to immunosuppressive microenvironment to predict unfavorable prognosis in inflammatory breast cancer

  2026cites this paper
• Regulatory T Cells in Ovarian Cancer: Insights into Cancer Immunotherapy.

  2026cites this paper
• Targeting Monocytes and Their Derivatives in Ovarian Cancer: Opportunities for Innovation in Prognosis and Therapy

  2026cites this paper
• Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer

  2025cites this paper
• Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements

  2025cites this paper
• Inducible T‐Cell Co‐Stimulator (ICOS) and ICOS Ligand: Dealing With a Two‐Faced Cancer Immunoregulatory System

  2025cites this paper
• Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside.

  2025cites this paper
• New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunity

  2025cites this paper
• Dendritic cells: the central partner for cancer immunity

  2025cites this paper
• Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy

  2025cites this paper
• Enhanced ICOS Signaling Between Dendritic Cells and T Cells Characterizes the Immune Landscape of Human Cholangiocarcinoma

  2025cites this paper
• Development of therapeutic cancer vaccines based on cancer immunity cycle

  2025cites this paper
• Depletion of plasmacytoid dendritic cells rescues HIV-reactive stem-like CD8+ T cells during chronic HIV-1 infection.

  2025cites this paper
• Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments.

  2025cites this paper
• Comprehensive analysis of m7G-related genes METTL1 and WDR4 for predicting prognosis and oncogenic functions in prostate cancer

  2025cites this paper
• Multi-omics and functional characterization of the tumor-killing capacity of Imiquimod-activated plasmacytoid dendritic cells

  2025cites this paper
• Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial.

  2025cites this paper
• CPT1A inhibition alleviates plasmacytoid dendritic cell-mediated immune suppression in colon cancer through fatty acid oxidation modulation

  2025cites this paper
• Harnessing dendritic cells as immunological bridges to potentiate mRNA cancer vaccines.

  2025cites this paper
• Acute myeloid leukemia with plasmacytoid dendritic cell differentiation initially presenting as skin lesions: A case report.

  2025cites this paper
• Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications

  2025cites this paper
• Targeting Myeloid Cells for Cancer Immunotherapy

  2025cites this paper
• Targeting the pDC/IFN-I axis in HIV-1 immunotherapy.

  2025cites this paper
• Construction and validation of a transmembrane 4 superfamily-related genes prognostic model for esophageal squamous cell carcinoma

  2025cites this paper
• ICOS-expressing Regulatory T Cells Influence the Composition of Antitumor CTL Populations.

  2024cites this paper
• Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling

  2024cites this paper
• Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer

  2024cites this paper
• The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment.

  2024cites this paper
• A novel ferroptosis-related gene signature for overall survival prediction in patients with gastric cancer

  2024cites this paper
• The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?

  2024cites this paper
• Dendritic Cells as a Therapeutic Strategy in Acute Myeloid Leukemia: Vaccines

  2024cites this paper
• Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8+ T lymphocyte infiltration in human laryngeal squamous cell carcinoma

  2024cites this paper
• Pre-existing skin-resident CD8 and gd T cell circuits mediate immune response in Merkel cell carcinoma and predict immunotherapy efficacy.

  2024cites this paper
• Dendritic Cells: Crucial Regulators of Immune Responses on Cancer Cells

  2024cites this paper
• Dendritic cell subsets and implications for cancer immunotherapy

  2024cites this paper
• Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how.

  2024cites this paper
• ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis

  2024cites this paper
• Assessment of pDCs functional capacity upon exposure to tumor-derived soluble factors.

  2024cites this paper
• CCL21 Induces Plasmacytoid Dendritic Cell Migration and Activation in a Mouse Model of Glioblastoma

  2024cites this paper
• S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130/JAK2/STAT3 signaling in acute myeloid leukemia.

  2024cites this paper
• T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression

  2024cites this paper
• Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy

  2024cites this paper
• Effector Functions of Dendritic Cells in Cancer: Role of Cytotoxicity and Growth Inhibition.

  2024cites this paper
• Cancer stem cell‐immune cell collusion in immunotherapy

  2023influential citation
• Dendritic Cell Vaccines in Ovarian Cancer: Have We Reached Their Potential?

  2023cites this paper
• A deep learning approach reveals unexplored landscape of viral expression in cancer

  2023cites this paper
• Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases

  2023cites this paper
• Distribution of DC Subtypes: CD83+, DC-LAMP+, CD1a+, CD1c+, CD123+, and DC-SIGN+ in the Tumor Microenvironment of Endometrial Cancers—Correlation with Clinicopathologic Features

  2023cites this paper
• ICOSLG acts as an oncogene to promote glycolysis, proliferation, migration, and invasion in gastric cancer cells.

  2023cites this paper
• Identification of a single cell-based signature for predicting prognosis risk and immunotherapy response in patients with glioblastoma.

  2023cites this paper
• Targeting the immune microenvironment for ovarian cancer therapy

  2023cites this paper
• The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis

  2023cites this paper
• Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity

  2023cites this paper
• Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer

  2023cites this paper
• Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma

  2023cites this paper
• Cancer cell-intrinsic mechanisms driving acquired immune tolerance.

  2023cites this paper
• First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators.

  2023cites this paper
• The Potential Immunomodulatory Effect of Bifidobacterium longum subsp. longum BB536 on Healthy Adults through Plasmacytoid Dendritic Cell Activation in the Peripheral Blood

  2023cites this paper
• CCR9-CCL25 mediated plasmacytoid dendritic cell homing and contributed the immunosuppressive microenvironment in gastric cancer

  2023cites this paper
• Reciprocal costimulatory molecules control the activation of mucosal type 3 innate lymphoid cells during engagement with B cells

  2023cites this paper
• Expression and prognosis of inducible T‐cell co‐stimulator and its ligand in Chinese stage I–III lung adenocarcinoma patients

  2023cites this paper
• Interplay between Signaling Pathways and Tumor Microenvironment Components: A Paradoxical Role in Colorectal Cancer

  2023cites this paper
• Harnessing dendritic cell diversity in cancer immunotherapy.

  2023cites this paper
• FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis

  2023cites this paper
• Phenotypes and Functions of Human Dendritic Cell Subsets in the Tumor Microenvironment.

  2023cites this paper
• Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance

  2023cites this paper
• Regulatory effects of IRF4 on immune cells in the tumor microenvironment

  2023cites this paper
• Epithelial Ovarian Cancer: Microenvironment and Immunecheck Point Inhibitors

  2023cites this paper
• Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients’ survival

  2022cites this paper
• Association between CD34+ and CD3+ T-cells in allogeneic grafts and acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation: A single-center study.

  2022cites this paper
• Transcriptome profile and clinical characterization of ICOS expression in gliomas

  2022cites this paper
• Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy

  2022cites this paper
• Early antitumor activity of oral Langerhans cells is compromised by a carcinogen

  2022cites this paper
• Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer

  2022cites this paper
• Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma

  2022cites this paper
• Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer

  2022cites this paper
• Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms

  2022cites this paper
• Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor

  2022cites this paper
• Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

  2022cites this paper
• Metastasis Role of myeloid cells in the tumor microenvironment

  2022cites this paper
• Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity

  2022cites this paper
• Human dendritic cells in cancer

  2022cites this paper
• Discordance in STING-Induced Activation and Cell Death Between Mouse and Human Dendritic Cell Populations

  2022cites this paper
• Epigenetics of Dendritic Cells in Tumor Immunology

  2022cites this paper
• Characterizing The Landscape Of Viral Expression In Cancer By Deep Learning

  2022cites this paper
• The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model

  2022cites this paper
• Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions

  2022influential citation
• Inflammation and Myeloid Cells in Cancer Progression and Metastasis

  2022cites this paper
• Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma

  2022cites this paper
• Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment.

  2022cites this paper
• The Role of Dendritic Cell Subsets in Recurrent Spontaneous Abortion and the Regulatory Effect of Baicalin on It

  2022cites this paper
• Therapeutic targeting of regulatory T cells in cancer.

  2022cites this paper
• An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia.

  2022cites this paper
• Immune cellular components and signaling pathways in the tumor microenvironment.

  2022cites this paper
• Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications

  2021cites this paper
• Intestinal Dysbiosis and Autoimmune Pancreatitis

  2021influential citation
• Activated neutrophils polarize protumorigenic interleukin‐17A‐producing T helper subsets through TNF‐α‐B7‐H2‐dependent pathway in human gastric cancer

  2021cites this paper
• Dendritic Cell Regulation of T Helper Cells.

  2021cites this paper
• Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential

  2021cites this paper
• Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment

  2021cites this paper